• Home_Hero
  • Home_Hero
  • Home_Hero
  • Home_Hero
jquery slider by WOWSlider.com v5.4
  • Home_Hero
  • Home_Hero
  • Home_Hero
  • Home_Hero
For Patients with Relapsing Forms of Multiple Sclerosis

FDA-Approved: Mylan’s
Glatiramer Acetate Injection
40 mg/mL

A Therapeutic Equivalent to 3-times-a-week 
Copaxone® (glatiramer acetate injection)
40 mg/mL

MS Advocate

24/7 Patient Support

You can depend on Mylan MS Advocate™ for in-home injection training and phone support from MS-experienced nurses-plus a $0 co-pay for eligible patients. Certain limits and restrictions apply.

Learn about Mylan MS Advocate

WhisperJECT Autoinjector

Mylan’s WhisperJECT Autoinjector device has features that were designed by patients, for patients.

WhisperJECT Autoinjector is available by Rx only.

See the features

Track Injections on Your Mobile Device

Download the Mylan Smart Injection Tracker™ app and track your Glatiramer Acetate injections on your mobile device. Track the injection sites you’ve used and get alerts for missed entries.

Download Now

App Store     Google Play


GLATIRAMER ACETATE INJECTION is a prescription medicine used for the treatment of people with relapsing forms of multiple sclerosis (MS).


Do not take GLATIRAMER ACETATE INJECTION if you are allergic to glatiramer acetate or mannitol.

Some patients report a short-term reaction right after injecting glatiramer acetate.  This reaction can involve flushing (feeling of warmth and/or redness), chest tightness or pain with heart palpitations, anxiety, and trouble breathing. These symptoms generally appear within minutes of an injection, last about 15 minutes, and do not require specific treatment.  There have been reports of patients with similar symptoms who received emergency medical care. If symptoms become severe, call the emergency phone numbers in your area.

Call your doctor right away if you develop hives, skin rash with irritation, dizziness, sweating, chest pain, trouble breathing, or severe pain at the injection site. If any of the above occurs, do not give yourself any more injections until your doctor tells you to begin again.

Chest pain may occur either as part of the immediate post-injection reaction or on its own. This pain should only last a few minutes. You may experience more than one such episode, usually beginning at least one month after starting treatment.

A permanent indentation under the skin (lipoatrophy and, rarely, death of your skin tissue also referred to as necrosis) at the injection site may occur due to local destruction of fat tissue. Be sure to follow proper injection technique and inform your doctor of any skin changes.

The most common side effects in studies of glatiramer acetate are redness, pain, swelling, itching, or a lump at the site of injection, flushing, rash, shortness of breath, and chest pain. These are not all of the possible side effects of GLATIRAMER ACETATE INJECTION. For a complete list, ask your doctor or pharmacist. Tell your doctor about any side effects that you have while taking GLATIRAMER ACETATE INJECTION.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Please see full Prescribing Information, Patient Information Leaflet, and Instructions for Use for Glatiramer Acetate Injection 20 mg/mL or Glatiramer Acetate Injection 40 mg/mL.